You are here
- Home
- Therapy Areas
- Gastrointestinal
TLESR-impedance Study in Patients
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Generic Name
- AZD3355
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- II
- Start Date
- Feb 19, 2007
- Study Name
- D9120C00020
- Study Id
- D9120C00020
- ClinicalTrials.gov ID
- NCT00743444
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
- Dec 2, 2008
